In comparison to breast and hepatocellular carcinomas, amplification rather than mutation in PIK3CA is a common event in ovarian carcinomas and is frequently associated with TP53 mutations [6], [7], [8]. This evidence concerns the gene TP53 and ovarian carcinoma.